TITLE

The birds -- be prepared!

AUTHOR(S)
Cheok Soh Hui; Odriscoll, Cath
PUB. DATE
August 2006
SOURCE
ICIS Chemical Business;8/14/2006, Vol. 1 Issue 31, p22
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article focuses on the efforts of pharmaceutical companies to develop diagnostic kits, vaccines and antivirals against bird flu in Asia. Take Veredus Laboratories is planning to launch an influenza chip by early 2007. Rockeby Biomed expanded its bird flu product portfolio by signing a distribution agreement with Anigen Diagnostics for its one-step test kit, VetScreen.
ACCESSION #
23158509

 

Related Articles

  • Home diagnostics. Popolillo, Melissa C. // Drug Store News;5/19/97, Vol. 19 Issue 9, p63 

    Examines drug chains' sales performance in home diagnostics in the United States in 1996 and in early 1997. Large sales of pregnancy test kits and blood glucose monitors; Improvements introduced by LifeScan and Boehringer-Manheim in glucose kits; Johnson & Johnson's introduction of the at-home...

  • Home diagnostics expands to offer better detection and management. Kyriakos, Tina // Drug Store News;4/6/98, Vol. 20 Issue 6, p15 

    Focuses on the expansion of the product offerings of drug store chains and manufacturers in the United States with the availability of home health diagnostic (HHD) devices. Factors driving the popularity of HHDs; Revenue increases from blood glucose monitoring products; Technological features...

  • When it comes to choosing home tests, pharmacists can help.  // Drug Topics;11/16/98, Vol. 142 Issue 22, p54 

    Focuses on the growing popularity of home diagnostic tests in the United States. Factors that drive home test sales; Advices to home testing kit sellers; Pharmacists' role in home testing kit market. INSETS: Home test never-out list;Home test competitive shop list.

  • Pandemic panacea. Chase, James // Medical Marketing & Media;Nov2005, Vol. 40 Issue 11, p6 

    Comments on the effort of pharmaceutical industry to develop drugs and vaccines against avian flu in the U.S. Availability of the Tamiflu, an antiviral drugs by Roche Group; Pressure from governments and the United Nations to develop the drugs; Inclusion of the license agreements with...

  • US evokes emergency act to keep flu at bay. MacKenzie, Debora // New Scientist;5/11/2013, Vol. 218 Issue 2916, p11 

    The article reports that the U.S. government gave an emergency authorization to diagnostic kits for the H7N9 avian influenza virus that have yet to be approved by the U.S. Food and Drug Administration (FDA), citing the potential public health risk posed by the disease. It is noted that although...

  • Molecular virology and translational research. Padmanaban, G. // Current Science (00113891);2/10/2010, Vol. 98 Issue 3, p305 

    In this article, the author discusses molecular virology and pathogenesis of viruses. The author suggests that studies on molecular virology should lead to strategies for diagnosis, prevention and cure for viral diseases. He says that affordable diagnostic kits should be made available in...

  • A race against time to diagnose bird flu. MacKenzie, Debora // New Scientist;2/4/2006, Vol. 189 Issue 2537, p30 

    The article focuses on efforts to diagnose avian flu strain. As H5N1 bird flu moves across Asia and into Europe, dozens of families, from China to Turkey, are spending days waiting for a verdict from government laboratories to confirm whether or not their loved one has the virus. There are...

  • New routes to bird flu drug.  // Pharmaceutical Technology Europe;Jun2006, Vol. 18 Issue 6, p10 

    The article reports that some individuals are stockpiling Roche's antiviral compound called Tamiflu because of concerns about the H5N1 strain of the avian influenza virus. The demand for Tamiflu is higher than supply and there is a fear that the supply chain wuld be unable to coped with the...

  • Antiinfluenza medication kits need work, FDA advisers conclude. Traynor, Kate // American Journal of Health-System Pharmacy;12/15/2008, Vol. 65 Issue 24, p2314 

    The article focuses on the conclusion drawn by advisers of the U.S. Food & Drug Administration (FDA) that antiinfluenza medication kits need work. About 20 experts voted that existing clinical data, supplemented with consumer-use studies are not sufficient to decide whether medkits are safe to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics